CryoVascular latest target of Boston buying spree
This article was originally published in Clinica
Executive Summary
Boston Scientific has exercised an option to acquire CryoVascular Systems, a maker of an angioplasty device to treat peripheral vascular disease. It was the Natick, Massachusetts company's third acquisition in four days.